Jubilant Pharmova Ltd (NSE:JUBLPHARMA) Share Price

Company Profile

Business description
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
Contact
1A, Sector 16A
NoidaUP201301
IND
T: +91 1204361000
https://www.jubilantpharmova.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
5,547

Recommended

We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.

Jon Mills, CFA | 11 September 2025

The magnitude of growth at Broadcom continues to astound us.

William Kerwin, CFA | 10 September 2025

The banking major needs to prevent key product offerings from falling further behind the competition.

Nathan Zaia | 10 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,067.50	13.00	-0.14%
CAC 40	7,761.32	11.93	0.15%
DAX 40	23,632.95	85.50	-0.36%
Dow JONES (US)	45,490.92	220.42	-0.48%
FTSE 100	9,225.39	17.14	-0.19%
HKSE	25,973.09	227.17	-0.87%
NASDAQ	21,886.06	6.57	0.03%
Nikkei 225	44,271.92	434.25	0.99%
NZX 50 Index	13,216.44	59.80	-0.45%
S&P 500	6,532.04	19.43	0.30%
S&P/ASX 200	8,800.60	13.20	-0.15%
SSE Composite Index	3,824.25	12.03	0.32%